Skip to main content

Find Clinical Trials

Home
Conditions
Hyperlipidemias

Clinical trial condition

Hyperlipidemias

Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.

691 public trials 57 recruiting studies

Refine in advanced search Browse all conditions

Hyperlipidemias trial results

Completed

Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study

NCT00225017

Conditions: Blood-Borne Infections, Communicable Diseases, Dyslipidemias, +18 more
Locations: University of California San Diego, California, United States

Northwestern Universtiy Chicago, Illinois, United States

Indiana University Indianapolis, Indiana, United States

University of Cincinnati Cincinnati, Ohio, United States

View Trial Details

Completed

A Study To Access The Safety And Tolerability Of RN316 (PF-04950615) When Administered To Healthy Adult Subjects

NCT00991159

Conditions: Dyslipidemias, Healthy, Hypercholesterolemia, +4 more
Locations: Pfizer Investigational Site Phoenix, Arizona, United States

Pfizer Investigational Site Miami Gardens, Florida, United States

View Trial Details

Completed

Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans

NCT01056549

Conditions: Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
Locations: Toronto General Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan

NCT01609907

Conditions: Cardiovascular Diseases, Dyslipidemias, Hyperlipidemia, +6 more
Locations: Yuhan Corporation Seoul, South Korea

View Trial Details

Completed

A Pilot Study to Improve Patient-Doctor Communication

NCT01606930

Conditions: Arthritis, Behavior, COPD, +30 more
Locations: Walter Reed National Medical Military Center (WRNMMC) Bethesda, Maryland, United States

View Trial Details

Completed

Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia

NCT00487994

Conditions: Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
Locations: Birmingham, Alabama, United States

Mobile, Alabama, United States

Northport, Alabama, United States

Chandler, Arizona, United States

View all 128 locations

View Trial Details

Completed

Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.

NCT00268697

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Tallinn, Estonia

Tartu, Estonia

Riga, Latvia

Moscow, Russia

View Trial Details

Completed

Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.

NCT00256178

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Benešov, Czechia

Holice V Čechách, Czechia

Kladno, Czechia

Mladá Boleslav, Czechia

View all 53 locations

View Trial Details

Completed

Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.

NCT00251680

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +7 more
Locations: Tucson, Arizona, United States

Artesia, California, United States

Jacksonville, Florida, United States

Dunwoody, Georgia, United States

View all 77 locations

View Trial Details

Completed

Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels

NCT00813527

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +4 more
Locations: Huntsville, Alabama, United States

Sierra Vista, Arizona, United States

Beverly Hills, California, United States

Long Beach, California, United States

View all 36 locations

View Trial Details